Even after adjusting for WHO severity classification, among other factors, Delta phase COVID-19 was associated with upregulation of multiple innate immune pathways, particularly inflammasome assembly, as well as NK and CD8+ T cell depletion, ROS generation, and impaired host protein synthesis. The gene discussed is CD8A; the disease is COVID-19.